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ABSTRACT 26 
Global stakeholders including the World Health Organization rely on predictive 27 
models for developing strategies and setting targets for tuberculosis care and control 28 
programs. Failure to account for variation in individual risk leads to substantial biases 29 
that impair data interpretation and policy decisions. Anticipated impediments to 30 
estimating heterogeneity for each parameter are discouraging despite considerable 31 
technical progress in recent years. Here we identify acquisition of infection as the 32 
single process where heterogeneity most fundamentally impacts model outputs, due to 33 
selection imposed by dynamic forces of infection. We introduce concrete metrics of 34 
risk inequality, demonstrate their utility in mathematical models, and pack the 35 
information into a risk inequality coefficient (RIC) which can be calculated and 36 
reported by national tuberculosis programs for use in policy development and 37 
modeling. 38 
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INTRODUCTION 40 
Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, 41 
accounting for over 10 million new cases annually1. Although allusions are often 42 
made to the disproportionate effect of TB on the poorest and socially marginalized 43 
groups2,3, robust metrics to quantify risk inequality in TB are lacking. Data reported 44 
by the World Health Organization (WHO), which mathematical models often rely on 45 
for calibrations and projections, are typically in the form of country-level averages 46 
that do not describe heterogeneity within populations. In keeping with the spirit of the 47 
Sustainable Development Goals agenda4, we postulate that mathematical models that 48 
account for heterogeneity and inequality may best reflect the potential impact of TB 49 
prevention and care strategies in achieving disease elimination. Further, we 50 
hypothesize that disease incidence patterns in a population reflect unobserved 51 
heterogeneity and may be used to inform model development and implementation. 52 
Variation in individual characteristics has a generally recognized impact on the 53 
dynamics of populations, and pathogen transmission is no exception5. In infectious 54 
diseases, heterogeneities in transmission have been shown to have specific effects on 55 
the basic reproduction number, R0, in ways which are unique to these systems6-10. In 56 
TB, as in other communicable diseases, this approach motivated the proliferation of 57 
efforts to collect data on contact patterns and superspreading events, to unravel 58 
processes that may affect transmission indices and models. The need to account for 59 
variation in disease risk, however, is not unfamiliar in epidemiology at large, where 60 
so-called frailty terms are more generally included in models to improve the accuracy 61 
of data analysis11. The premise is that variation in the risk of acquiring a disease 62 
(whether infectious or not) goes beyond what is captured by measured factors 63 
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(typically age, malnutrition, comorbidities, habits, social contacts, etc), and a 64 
distribution of unobserved heterogeneity can be inferred from incidence trends in a 65 
holistic manner. Such distributions are needed for eliminating biases in interpretation 66 
and prediction12,13, and can be utilized in conjunction with more common reductionist 67 
approaches, which are required when there is desire to target interventions at 68 
individuals with specific characteristics. 69 
Individual risk of infection or disease relates to a probability of responding to a 70 
stimulus and, therefore, direct measurement would require the recording of responses 71 
to many exposures to obtain the frequency at which the outcome of interest occurs. In 72 
TB, this is unfeasible due to the relatively low frequency of disease episodes and the 73 
extremely variable time period between exposure and disease development, but may 74 
be approximated by sub-dividing the population in sufficiently large groups and 75 
recording occurrences in each of them. Then incidence rates can be calculated per 76 
group, and ranked. Supplementary Fig. 1 illustrates the population of a hypothetical 77 
country comprising low and high risk individuals distributed geographically (but 78 
dividing by age or income level, for example, applied singly or in combination, could 79 
also serve our statistical purposes). Forasmuch as individuals are nonuniformly 80 
distributed, disease incidence will vary between groups and carry information about 81 
variation in individual risks.  82 
Here we adopt concepts and tools developed in economics to measure inequality in 83 
wealth, such as the Lorenz curve14 and the Gini coefficient15, and modify them into 84 
suitable indicators of disease risk inequality. We then calculate a risk inequality 85 
coefficient for three countries – Vietnam, Brazil and Portugal, representing high to 86 
low TB burdens – and derive country-specific risk distributions to inform 87 
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transmission models. The resulting models are applied to investigate the conditions 88 
for reducing TB incidence by 90% between 2015 and 2035, one of the targets set by 89 
the WHO’s End TB Strategy16. The results differ significantly from those obtained by 90 
a homogeneous approximation of the same models. We find that by considering 91 
heterogeneity, control efforts result in a lower impact on disease burden, except in 92 
special circumstances which we highlight. More generally, we elucidate how model 93 
predictability relies on certain forms of heterogeneity but not others, and propose a 94 
practical scheme for summarizing inequality in disease risk to be used in modeling 95 
and policy development for TB and other diseases. 96 
RESULTS 97 
Risk inequality coefficient (RIC) 98 
Fig. 1 depicts Lorenz curves14 for TB occurrences in the populations of Vietnam, 99 
Brazil and Portugal structured by municipalities (level 2 administrative divisions), 100 
enabling the calculation of a Gini coefficient15 that we refer to as the risk inequality 101 
coefficient (RIC) (Methods). To inform mathematical models of TB transmission with 102 
two risk groups12,17, we discretize risk such that 4% of the population experiences 103 
higher risk than the remaining 96%. This cut-off is consistent with previous 104 
studies17,18, although it could have been set arbitrarily as the procedure does not 105 
depend on how we discretize what is conceivably a continuous risk distribution. The 106 
Lorenz curves corresponding to the discretization, which are depicted by the dashed 107 
lines in Fig. 1a, are then used as an approximation to the original solid curves with the 108 
same RIC. 109 
RIC-compliant transmission models 110 
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Inequality in TB risk among individuals was implemented in three processes which 111 
were analyzed in alternation (Methods; parameters in Table 1): (i) contact rates; (ii) 112 
susceptibility to infection; and (iii) progression from primary infection to active 113 
disease. This study is primarily devoted to heterogeneity in contact rates, while the 114 
other two modalities are included for comparative purposes. Although the models 115 
differ in the precise implementation of the relative risk parameters (𝛼" and 𝛼#), in all 116 
three cases these can be calculated exactly and simultaneously with the mean 117 
effective contact rate (𝛽), so as to match the country-specific incidence patterns 118 
reported for the first year in the data series.  119 
The procedure was applied to data from Vietnam, Brazil and Portugal (Fig. 2, for 120 
heterogeneous contact rates), resulting in risk variances of 10.5 in Vietnam, 11.1 in 121 
Brazil and 5.63 in Portugal. Notice that these variances are consistently higher than 122 
the observed variances in TB incidence (2.3 in Vietnam, 5.1 in Brazil and 2.7 in 123 
Portugal), indicating that transmission masks risk heterogeneity to some extent and 124 
we need to resort to models for the inference of total variances11. Model outputs were 125 
then analyzed in-depth revealing a poor predictive capacity of homogeneous models 126 
and leading to the identification of acquisition of infection as the single most 127 
important process behind model disparities.  128 
The risk distributions represented inside the various epidemiological compartments in 129 
Fig. 2b, e, h, are key to understanding why model outputs diverge. Mean risks have 130 
been normalized to one in all countries (i.e. the distributions in Fig. 2a, d, g have 131 
mean one), but as the system runs to endemic equilibrium high-risk individuals are 132 
infected predominantly. In other words, high-risk individuals are selected out of the 133 
uninfected compartment when a force of infection is in operation. As a result, the 134 
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mean risk in the uninfected compartment decreases, decelerating the epidemic to the 135 
extent that the uninfected pool sustains transmission. This effect is greater for stronger 136 
forces of infection and larger risk variances, consistently with the mean risks 137 
displayed inside square brackets for the various epidemiological compartments. A 138 
similar process occurs for all epidemiological compartment where individuals are at 139 
risk of infection (i.e. uninfected (U) and latent (L) in the case of the model adopted 140 
here). 141 
Risk inequality as a compromiser of intervention impact 142 
The heterogeneous contact-rate model initiated according to 2002 incidences (Fig. 2) 143 
was run forward in time with a constant decay rate in reactivation to meet an arbitrary 144 
fixed target of halving the incidence in 10 years (Fig. 3b, d, f, black curves). If these 145 
estimations (exact calculations in this case) and projections had been made by the 146 
homogeneous model, the required control efforts would have been underestimated 147 
and the target systematically missed (Methods; Supplementary Table 1), with relative 148 
errors around 20-30% for Vietnam, 25-40% for Brazil and 10-20% for Portugal 149 
(colored curves). This is because the force of infection decreases as the intervention 150 
progresses, reducing the strength of selection described above, which in turn allows 151 
for increasing mean risks in compartments at risk of infection (Fig. 3a, c, e), 152 
counteracting the intended effects of the intervention. Homogeneous models 153 
artificially disable this selection process, creating an illusion that control targets are 154 
moving when observed from a homogeneous frame.  155 
This is a general phenomenon in infectious diseases, although there may be 156 
exceptional circumstances where the sign of the effect may be reversed as detailed 157 
below. In any case, it is a systematic error (bias) not to be confused with uncertainty 158 
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in parameter estimates19,20. 159 
Meeting WHO’s End TB incidence targets 160 
The models were used to reproduce reported country-level trends for TB incidence in 161 
Vietnam, Brazil and Portugal. Following initialization in 2002 as above, the model 162 
was fitted to the incidence declines reported by WHO until 2015. In the first instance 163 
we explored how much reactivation should have decreased had the observed 164 
incidence declines been attributed to changing this parameter alone at a constant rate 165 
(Supplementary Table 2). This was performed numerically by a binary search 166 
algorithm designed to meet 2015 incidences (Fig. 4). Trajectories were then 167 
prolonged until 2050 (dashed segments in the same figure) suggesting the need for 168 
increased efforts to meet the End TB incidence targets (2035 targets marked by dotted 169 
lines). This initial exploration was completed by the introduction of a scale-up 170 
parameter (𝜅) to account for increased reductions in reactivation from 2020 onwards 171 
and estimating the necessary scaling to meet the 2035 target in each country 172 
(displayed as “× 𝜅” in the figure). As above, the homogeneous model consistently 173 
underestimates the required control efforts. In the following we refer to this as the 174 
default expectation when comparing the outcomes of the same investigation strategy 175 
applied to more realistic scenarios where incidence declines are attributed to a 176 
combination of parameters. 177 
When incidence declines are attributed to reductions in the probability of progressing 178 
from primary infection to active disease (𝜙, with the remaining 1 − 𝜙 maintaining a 179 
latent infection) as well as reactivation (𝜔), estimating the two decay rates is not 180 
possible with a simple binary search algorithm and we use a Bayesian Markov Chain 181 
Monte Carlo (MCMC) approach (Methods). Fig. 5 depicts the declining annual 182 
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incidences and model trajectories, based on the means and 95% credible intervals of 183 
the posterior distributions of decay rates in 𝜙 and 𝜔 (Supplementary Table 3), 184 
prolonged until 2020. Also in this scenario, control measures must be intensified for 185 
meeting the ambitious End TB targets. We apply the scaling factor k uniformly to the 186 
decay rates of the two parameters and estimate the required effort intensification. 187 
Heterogeneous contact-rate (Fig. 5a, c, e) and homogeneous (Fig. 5b, d, f) models are 188 
similarly effective at capturing the data, but require significantly different scale-up 189 
efforts (Supplementary Table 4). In contrast with the case where only reactivation was 190 
reduced, we now get an indication that Brazil requires less effort intensification under 191 
heterogeneity (in relation to that predicted by the homogeneous model) while 192 
Vietnam and Portugal comply with the default expectation. Inspection into the percent 193 
reduction curves for the two parameters reveals that scale-up tends to be more 194 
effective when the initial decline (pre-scale-up) is predominantly attributed to 195 
reducing reactivation (homogeneous in Vietnam and Portugal; heterogeneous in 196 
Brazil). 197 
Under heterogeneous contact rates, the incidence declines observed in Vietnam and 198 
Portugal have been predominantly attributed to reducing progression to disease from 199 
recent infection (Fig. 5a, e; bottom panels show blue curve above red in pre-scale-up 200 
phase). Given the assumption of identical scaling factors for both processes, the 201 
reduction in 𝜙 (blue) reaches saturation soon after scale-up is initiated leaving most of 202 
the remaining effort to 𝜔 (red) and inflating the required scaling efforts. 203 
Contrastingly, in Brazil the incidence decline has been largely attributed to reducing 204 
disease arising from reactivation (Fig. 5c; bottom panel shows red curve above blue 205 
pre-scale-up) leaving the reduction in 𝜙 far from saturation and creates a scenario 206 
where reducing progression maintains substantial potential to generate further impact 207 
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after scaling. 208 
Naturally, there is no reason for scale-up factors to be the same for the two processes, 209 
and this result suggest that new ways to reduce reactivation are needed in Vietnam 210 
and Portugal. In relation to that, it also raises the importance of understanding what 211 
may have led to the declining reactivation rates in Brazil and how might other 212 
countries achieve similar goals. More detailed datasets should be interrogated in 213 
search for answers, but this is potentially due to especially intense social protection 214 
programs implemented over recent decades in Brazil21-25, leading to improved health 215 
conditions in population segments classically more at risk for TB. 216 
The parameters that have been most commonly varied to explain incidence trends in 217 
modeling studies are rates of successful treatment (𝜏) and mean effective contacts 218 
(𝛽)26. For completion and comparability with other studies we conceive additional 219 
scenarios where the observed declines in incidence are attributed to decays in 𝜏 and 220 
w (Supplementary Fig. 2 and Supplementary Tables 5 and 7) or 𝛽 and 221 
w (Supplementary Fig. 3 and Supplementary Tables 6 and 7), and infer the respective 222 
attributions as above. In both cases the scaling in control efforts required to meet End 223 
TB incidence targets appears lower under heterogeneity. This seems counter-intuitive 224 
at first but see the values of 𝑅- plotted as insets in Figs. 4, 5 and Supplementary Figs. 225 
2, 3. During the scale-up phase, this transmission index is consistently below one in 226 
the homogeneous implementation and above one when heterogeneity is considered. 227 
Since 𝜏 and 𝛽 relate to ongoing transmission, scaling changes in these parameters is 228 
not effective at reducing incidence when 𝑅- < 1 and, consequently, the homogeneous 229 
implementations must rely on the reduction in 𝜔 alone to meet the targets. This 230 
process results in the inflation of the scale parameter 𝜅 observed under homogeneity 231 
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and reversion of the default expectation. The sensitivity of our conclusions to which 232 
parameters are actually varying in each setting reinforces the need for more 233 
discriminatory data and dedicated studies.  234 
Results presented so far addressed heterogeneity in contacts rates, which implicitly 235 
considers that acquisition of infection is positively correlated with transmission to 236 
others5,8,9,10,12,18. But irrespective of how present heterogeneity in contact rates is in 237 
TB dynamics, there is a myriad of biological factors which contribute to making 238 
individuals different and may affect TB incidence patterns. 239 
Fig. 6 (and Supplementary Table 8) shows the results obtained by employing the 240 
same procedures as in Fig. 5 but assuming that heterogeneity affects susceptibility of 241 
infection given exposure, rather than the rate of contacts. The two variants are in fact 242 
described by the same model, except for how the force of infection is formulated 243 
(Methods). Essentially, if we write the force of infection as 𝜆 = 𝛽(𝜌"𝐼" + 𝜌#𝐼#), 244 
where the new parameters 𝜌" and 𝜌# represent the relative infectivities of individuals 245 
in risk groups 1 and 2, respectively,  heterogeneity in contact rates12 is retrieved when 246 𝜌6 = 𝛼6 and heterogeneity in susceptibility17 is obtained by imposing 𝜌6 = 1, while a 247 
combination of the two would correspond to values in between. 248 
The agreement between Figs. 5 and 6 supports the notion that the results are mostly 249 
insensitive to whether heterogeneity affects primarily contact rates or susceptibility to 250 
infection, but the case of Vietnam deserves a special note. Under the heterogeneous 251 
susceptibility formulation, the contribution of reducing reactivation to the decline in 252 
incidence is more evident than under heterogeneous contact rates (Fig. 6b). As a result 253 
the scaling factor required to meet the 2035 incidence target is substantially reduced. 254 
This is not sufficient to reverse the default conclusion that the homogeneous model 255 
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underestimates control efforts (as it happens again in Brazil), but it brings the 256 
estimated scaling factor closer to that estimated by the homogeneous model. It 257 
follows that any combination of the two forms of heterogeneity is expected to lead to 258 
the same qualitative conclusions, whereas, quantitatively, the findings for Brazil and 259 
Portugal are confined to narrow ranges while for Vietnam they are highly sensitive to 260 
how individual predisposition to acquire infection correlates with propensity to infect 261 
others. In any case, all the results presented so far imply heterogeneity in acquisition 262 
of infection.  263 
The results presented are in stark contrast with forms of heterogeneity that do not 264 
affect acquisition of infection. Fig. 7 (and Supplementary Table 9) shows that when 265 
heterogeneity is in the probability of progression from primary infection to active 266 
disease, model outputs do not deviate from the homogeneous implementation. This is 267 
because progression is not under the selection mechanisms described earlier in the 268 
paper, as demonstrated by the mean risk among susceptible compartments remaining 269 
flat at the value one (Fig. 7b) by contrast with what has been noted under 270 
heterogeneous contact rates, for example (Fig. 3a, c, e). Similarly, heterogeneity in 271 
rates of reactivation or treatment success should generally not lead to different model 272 
outputs unless correlated with predisposition for acquiring infection. This confirms 273 
our earlier premise that variation in acquisition of infection is the single most 274 
important process behind the disparities between homogeneous and heterogeneous 275 
models, and hence the most important to estimate. 276 
In further account to sensitivity analysis we show that the original results of Fig. 5 are 277 
robust to whether individuals clear the infection upon treatment or maintain a latent 278 
infection (Supplementary Fig. 4 and Supplementary Table 10). 279 
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Prevalence of latent TB infection 280 
Prevalence of latent TB infection (LTBI) calculated from model trajectories generated 281 
by our heterogeneous models (27.0-28.9% in Vietnam, 15.2-16.1% in Brazil, and 282 
16.9-18.0% in Portugal, in 2014; Supplementary Table 11) are generally consistent 283 
with estimates from a recent study27. This is irrespective of whether heterogeneity is 284 
in contact rates or susceptibility to infection. Even though these percentages are 285 
somewhat smaller than those expected under the homogeneous model, the reservoir 286 
must nevertheless be contained in all three countries if incidence targets are to be met.  287 
DISCUSSION 288 
The notion that heterogeneity affects the results of population models and analyses is 289 
not new5,28-32, but we still face a general inability to measure it. We propose a 290 
concrete way forward for infectious disease transmission models, which is based on 291 
routinely collected data. Measures of statistical dispersion (such as Lorenz curves14 292 
and Gini coefficients15) are commonly used in economics to represent the distribution 293 
of wealth among individuals in a country and to compare inequality between 294 
countries, but rarely used in epidemiology33,34. Measuring disease risk of an 295 
individual is less direct than measuring income, but surely this can be overcome in 296 
creative ways for classes of diseases.  297 
We have focused on tuberculosis, and shown how to approximate distributions of 298 
individual risk from suitably structured disease notification and population data (Fig. 299 
1; Supplementary Fig. 1), and how to summarize the information into a simple risk 300 
inequality coefficient (RIC = 0.30 in Vietnam, RIC = 0.46 in Brazil, and RIC = 0.32 301 
in Portugal), analogous to the Gini coefficients calculated by the World Bank to 302 
describe inequality in the distribution of wealth (0.38 in Vietnam, 0.51 in Brazil, and 303 
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0.36 in Portugal). Because they are based on the use of disease estimates at the level 304 
of administrative divisions within countries, there are limits to the accuracy of the 305 
RIC estimates, especially due to misreporting, which may be more severe in some 306 
countries than others. Other uses of the Gini coefficient, however, face the similar 307 
limitations while the methodology is still used to drive policy and program decisions 308 
and is improved upon as better data and formalisms become available. Importantly, 309 
the availability of comparable inequality metrics in economics and health can pave 310 
the way to pertinent studies between income inequality and health and provide a basis 311 
for equity considerations in policy development35, a major component of the 312 
Sustainable Development Goals agenda4. In addition, we have demonstrated how to 313 
input this information into tractable mathematical models and why this is essential to 314 
accuracy and predictive capacity of these decision-making tools.  315 
The approach followed here is in sharp contrast with those based on explicit 316 
metapopulation models36-38. We use incidence data of a country stratified into its 317 
administrative (geographical) divisions as a means to infer variation in disease risk 318 
among individuals, rather than as a direct measure of variation between the divisions 319 
themselves. To highlight this distinction we built a metapopulation model consisting 320 
of two subpopulations (patches), each with its intrinsic individual variation, and 321 
constrain the outputs to be consistent with patch incidences (Methods; Supplementary 322 
Fig. 5), according to data from our study countries (Fig. 1). This sets a mathematical 323 
problem which can be solved over a range of country-level variances in individual 324 
risk (Supplementary Figs. 6 and 7), and for each variance there is an exact value of 𝑅- 325 
that makes the metapopulation model compatible with the stratified incidence data. 326 
The result is a curve describing 𝑅- as a function of variance in individual risk which 327 
is plotted in Fig. 8 together with the corresponding metrics obtained from the models 328 
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used in this study (circles). The common practice of implementing a metapopulation 329 
without individual variation within subpopulations (lower limit of the curve), disables 330 
the action of selection at the individual level and carries similar biases to those 331 
present in homogeneous models (open circles). As individual variation increases, the 332 
curve approaches our heterogeneous models (filled circles), supporting the notion that 333 
the models proposed in this paper represent the dynamics of an average location 334 
within a country (with variation captured down to the individual level), in contrast 335 
with standard metapopulation models which describe an entire country structured into 336 
patches (with differentiation between patches but neglecting individual variation 337 
within).  338 
Strikingly, the figure highlights an essential need for representing heterogeneity at the 339 
finest level if transmission indices are to be estimated accurately. In placing the 340 
models adopted here in the wider context of TB models with the same structure 341 
whose outputs are compatible with stratified incidence data for Vietnam, Brazil and 342 
Portugal, the figure also reveals one potential limitation of the approach. The range of 343 
variances (and associated 𝑅- values) compatible with the data is wide and this is 344 
arguably the greatest current attrition to reaching high levels of certainty on 345 
parameters and predictions. This can be improved by combining multiple schemes for 346 
stratifying country incidence data alongside the development of more sophisticated 347 
methods for inferring variation in individual risk from patterns in the data. 348 
In conclusion, the worldwide adoption of risk inequality metrics, such as the RIC 349 
proposed here or similar, has the potential to prompt an explosion of creativity in 350 
mathematical modeling, but it can also enable policymakers to assess risk inequality 351 
in each country, compare the metric across countries, and monitor the impact of 352 
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equalization strategies and targeted interventions over time. 353 
METHODS 354 
Lorenz curves and risk inequality coefficients 355 
Lorenz curves14 are widely used in economics to calculate indices of inequality in the 356 
distribution of wealth, known as Gini coefficients15. Although rarely used in 357 
epidemiology, similar metrics can be adopted to describe inequalities in disease 358 
risk33,34. Here we construct a Lorenz curve for each study country from TB 359 
notifications and population data structured by municipalities (level 2 administrative 360 
divisions). Municipalities are ordered by incidence rates (from low to high) and 361 
cumulative TB notifications are plotted against cumulative population (both in 362 
percentages). By construction, this results in a convex curve between (0,0) and 363 (100,100), which would be a straight line in the absence of inequality. A risk 364 
inequality coefficient (RIC) can be calculated as the ratio of the area between the 365 
curve and the equality line, over the area of the triangle under the equality line. This 366 
gives a number between 0 and 1, which is analogous to the Gini coefficient 367 
commonly used to summarize income inequality, with the exception that while 368 
income can be measured at the individual level the assessment of TB risk cannot be 369 
made by analyzing individuals directly, but must be approximated from group 370 
measurements. 371 
Supplementary Fig. 8 compares alternative Lorenz curves generated for Vietnam, 372 
Brazil and Portugal to explore the effects of timespan and group size. As we must 373 
comply with the administrative divisions already established in each country, level 2 374 
appears to offer the best compromise between resolution (the smaller the units, the 375 
closer we get to measuring individual risk) and occurrences (the larger the units, the 376 
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larger the numbers and the more accurate the risk discrimination39). Regarding 377 
timespan, the longer the data series the better. We used 10 years (2006-2015) in 378 
Vietnam and 14 years (2002-2015) in Brazil and Portugal to generate the respective 379 
RIC values. 380 
We then use the RIC to inform risk distributions for TB transmission models. The 381 
Lorenz curves utilized to obtain RIC values consist of many segments (as many as 382 
administrative divisions; 696 in Vietnam, 5127 in Brazil and 308 in Portugal). To 383 
keep our models tractable and low dimensional without compromising the overall 384 
variance in risk we construct two-segment Lorenz curves with the same RIC as the 385 
original and use this approximation to infer risk distributions for our TB models. 386 
Mathematical models  387 
We adopt a TB transmission model which is adapted from previously published 388 
studies12,17, to represent risk heterogeneity in three alternative ways. 389 
(i) Heterogeneity in contact rates: 390 
𝑑𝑈6𝑑𝑡 = 𝑞6𝜇 + 𝜃𝜏𝐼6 − 𝜆6𝑈6 − 𝜇𝑈6																																																																																					(1) 391 𝑑𝑃6𝑑𝑡 = 𝜆6(𝑈6 + 𝐿6) − (𝛿 + 𝜇)𝑃6																																																																																						(2) 392 𝑑𝐼6𝑑𝑡 = 𝜙𝛿𝑃6 + 𝜔𝐿6 − (𝜏 + 𝜇)𝐼6																																																																																							(3) 393 𝑑𝐿6𝑑𝑡 = (1 − 𝜙)𝛿𝑃6 + (1 − 𝜃)𝜏𝐼6 − 𝜆6𝐿6 − (𝜔 + 𝜇)𝐿6,																																														(4) 394 
where subscripts i = 1,2 denote low and high risk groups that individuals enter at birth 395 
in proportions 𝑞" and 𝑞#, respectively. Within each group individuals are classified, 396 
according to their infection history, into uninfected (𝑈6), or infected in one of three 397 
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possible states: primary infection (𝑃6); latent infection (𝐿6); and active tuberculosis 398 
disease (𝐼6) which is the infectious state. The model parameters along with their 399 
typical values used herein are listed in Table 1. The force of infection upon uninfected 400 
individuals is 401 
𝜆6 = 𝛼6〈𝛼〉 𝛽(𝛼"𝐼" + 𝛼#𝐼#),																																																																																																		(5) 402 
where 𝛼6 is a modifier of risk (contact rate in this case) of individuals in group i in 403 
relation to the population mean 〈𝛼〉 = 𝑞"𝛼" + 𝑞#𝛼# = 1, and the basic reproduction 404 
number is 405 
𝑅- = 〈𝛼#〉〈𝛼〉 N 𝜔 + 𝜇𝜇(𝜏 + 𝜔 + 𝜇) + 𝜃𝜏𝜔O P 𝜙𝛿𝛿 + 𝜇 + (1 − 𝜙)𝛿𝜔(𝛿 + 𝜇)(𝜔 + 𝜇)Q 𝛽,																										(6) 406 
Where 〈𝛼#〉 is the second moment of the risk distribution, i.e. 〈𝛼#〉 = 𝑞"𝛼"# + 𝑞#𝛼##. 407 
For simplicity we have assumed individuals to mix uniformly irrespectively of risk 408 
group.  409 
(ii) Heterogeneity in susceptibility to infection: 410 
When risk heterogeneity is attributed to susceptibility to infection the model is still 411 
written as in (1)-(4), but the force of infection upon uninfected individuals becomes 412 
𝜆6 = 𝛼6𝛽(𝐼" + 𝐼#),																																																																																																													(7) 413 
where 𝛼6 is the susceptibility of individuals in group i in relation to the population 414 
mean 〈𝛼〉 = 𝑞"𝛼" + 𝑞#𝛼# = 1. The basic reproduction number for this model is 415 
𝑅- = 〈𝛼〉 N 𝜔 + 𝜇𝜇(𝜏 + 𝜔 + 𝜇) + 𝜃𝜏𝜔O P 𝜙𝛿𝛿 + 𝜇 + (1 − 𝜙)𝛿𝜔(𝛿 + 𝜇)(𝜔 + 𝜇)Q 𝛽.																													(8) 416 
(iii) Heterogeneity in progression from primary infection to disease: 417 
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When risk heterogeneity is attributed to factors that affect the probability of progression 418 
from primary infection to active disease, the model takes the form 419 𝑑𝑈6𝑑𝑡 = 𝑞6𝜇 + 𝜃𝜏𝐼6 − 𝜆𝑈6 − 𝜇𝑈6																																																																																							(9) 420 𝑑𝑃6𝑑𝑡 = 𝜆(𝑈6 + 𝐿6) − (𝛿 + 𝜇)𝑃6																																																																																					(10) 421 𝑑𝐼6𝑑𝑡 = 𝜙6𝛿𝑃6 + 𝜔𝐿6 − (𝜏 + 𝜇)𝐼6																																																																																				(11) 422 	𝑑𝐿6𝑑𝑡 = (1 − 𝜙6)𝛿𝑃6 + (1 − 𝜃)𝜏𝐼6 − 𝜆𝐿6 − (𝜔 + 𝜇)𝐿6,																																											(12) 423 
with force of infection 424 
𝜆 = 𝛽(𝐼" + 𝐼#),																																																																																																																	(13) 425 
and 𝜙6 = 𝛼6𝜙, representing the probability of progression from primary infection to 426 
disease for individuals in group i in relation to the population mean 〈𝛼〉 = 𝑞"𝛼" +427 𝑞#𝛼# = 1. The basic reproduction number for this model is 428 
𝑅- = N 𝜔 + 𝜇𝜇(𝜏 + 𝜔 + 𝜇) + 𝜃𝜏𝜔O P〈𝛼〉𝜙𝛿𝛿 + 𝜇 + (1 − 〈𝛼〉𝜙)𝛿𝜔(𝛿 + 𝜇)(𝜔 + 𝜇)Q𝛽.																																(14) 429 
In all cases we use risk and risk distribution as generic terms to designate factors of 430 
variation in the predisposition of individuals to acquire infection or disease, which 431 
may be realized physically as rates of contacts with other individuals (i), or 432 
biologically as susceptibility to infection given exposure (ii) or progression to disease 433 
given infection (iii). We use the terminology epidemiological compartment to refer to 434 
the composite of all compartments for the same infection status (i.e. uninfected 435 
comprises both 𝑈" and 𝑈#, etc). We also introduce the notion of mean risk for each 436 
epidemiological compartment to track selection (e.g. the mean risk for 𝑈(𝑡) is 437 
calculated as (𝑈"(𝑡)𝛼" + 𝑈#(𝑡)𝛼#) (𝑈"(𝑡) + 𝑈#(𝑡))⁄ , etc). We adopt two risk groups 438 
for concreteness, but formalisms with more groups would essentially support the 439 
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same phenomena. Indeed, two recent studies implemented similar selection processes 440 
within populations structured into hundreds of risk groups40,41. 441 
The models accommodate an endemic equilibrium when R0 > 1, as displayed by the 442 
solution curves parameterized by 𝛽 in Supplementary Figs. 9, 10 and Fig. 7a. 443 
Incidence rates in each risk group are approximated from model outputs by adding the 444 
positive terms in 𝑑𝐼6 𝑑𝑡⁄  and dividing by the population in that group, i.e. 445 V𝜙(6)𝛿𝑃6 + 𝜔𝐿6W 𝑞6⁄  per year, and for the entire population as the weighted sum of 446 
these over risk groups. 447 
Model initialization 448 
Model trajectories are initialized assuming equilibrium conditions in 2002. 449 
Parameters describing the rates of birth and death of the population, the probability of 450 
progression from primary infection to active disease, and the rate of successful 451 
treatment, are set at the same values for the three countries: 𝜇 = 1 80⁄ 	𝑦𝑟Z"; 𝜙 =452 0.05 (Ref. 42),  𝜏 = 2	𝑦𝑟Z"(Ref. 43). The rate of reactivation is considered three 453 
times higher in South East Asian than in Western populations: 𝜔 = 0.0013	𝑦𝑟Z" in 454 
Brazil and Portugal; 𝜔 = 0.0039	𝑦𝑟Z" in Vietnam (Ref. 44). The mean effective 455 
contact rate (b) was calibrated to enable model solutions to meet country-level 456 
incidences estimated by the WHO for 2002 (Supplementary Figs. 9, 10 and Fig. 7a). 457 
Risk group frequencies are set at 𝑞" = 0.96, and 𝑞# = 0.04, and the relative risk 458 
parameters (𝛼" and 𝛼#) estimated as described below. The results are then displayed 459 
in terms of the non-dimensional parameter 𝑅-, which is linearly related to 𝛽 460 
according to (6), (8), (14). 461 
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The same procedure was carried out for the mean field approximations of the 462 
respective models. At this point it can be confirmed that 𝑅- estimates are typically 463 
higher under heterogeneity12. We adopt heterogeneity in contact rates (i) as the default 464 
model throughout the paper, and use the susceptibility (ii) and disease progression 465 
(iii) variants for completion. Hence, unless specified otherwise, the results shown in 466 
the paper refer to heterogeneity in contact rates. 467 
Risk distributions 468 
Given a Lorenz curve (Fig 1a), any discretization can be assumed to define how 469 
concentration of risk will enter the model. We adopt a division into 96% low-risk and 470 
4% high-risk groups, but the procedure is not specific to the chosen discretization. A 471 
distribution of incidences is then constructed as to produce the same RIC as the 472 
original curve: a segment 𝑞" = 0.96 of the population accounts for (100 − 𝑦)% of 473 
the incidence, while the remaining segment 𝑞# = 0.04 accounts for the remaining 𝑦% 474 
(Fig 1a). The transmission model is solved as above, and the relative risk parameters 475 𝛼6 are calculated (Fig. 2a, d, g) so as to output the country-specific incidence 476 
distributions (see Fig. 2c, f, i). This was performed numerically by binary search to 477 
adjust the variance in the parameters 𝛼6 such that the variance in the output incidences 478 
agrees with the notification data.  479 
Under any positive force of infection, the two risk groups segregate differently to 480 
populate the various epidemiological compartments, as depicted in Fig. 2b, e, h, 481 
resulting in mean risks that differ from one for specific compartments, and thereby 482 
deviating from homogeneous approximations. Crucially, the mean risks among 483 
individuals that occupy the various epidemiological compartments (square brackets in 484 
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the figure) respond to dynamic forces of infection causing divergence from 485 
predictions made by homogenous models. 486 
Moving targets 487 
The model, with the estimated risk distributions, parameters, and initial conditions, 488 
fitting the 2002 incidences (189 in Vietnam, 52 in Brazil, and 49 in Portugal, all per 489 
100,000 person-years), is run forward in time with a constant decline in reactivation 490 
rate as to meet an arbitrarily fixed target of halving the incidence in 10 years. As in 491 
the calculation of risk variance above, also here we refer to a simple numerical 492 
calculation performed by binary search. We write the reactivation rate as 𝜔(𝑡) =493 𝜔(0)e]^ (_Z#--#) per year, and approximate 𝑟  in order to meet the desired incidence 494 
target by year 2012. 495 
Starting with initial reactivation rates of 0.0039 per year in Vietnam, and 0.0013 per 496 
year in Brazil and Portugal, we find that meeting the target by this strategy alone, 497 
would require values of  𝑟  as specified in the heterogeneous column of 498 
Supplementary Table 1, or equivalently a decline in reactivation by 1 − e]^  each 499 
year. This is to say that, in 10 years, the reactivation rates would have been reduced to 500 
values also shown in the respective column of Supplementary Table 1. 501 
Suppose that these estimations and projections were being made by the mean field 502 
approximation of the same model, and the outcomes were monitored yearly and 503 
readjusted if necessary. The expectations would have been that lower absolute values 504 
would be required for the decay rate parameters 𝑟 . Since the real population is 505 
heterogeneous, however, we simulate this decline for the first year with the 506 
heterogeneous model. The result is that, instead of achieving the incidences projected 507 
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by the homogeneous model (“target” homogeneous column in Supplementary Table 508 
1), the reality would lag behind (“achieved” homogeneous column in Supplementary 509 
Table 1), a result that the homogeneous model would attribute to insufficient effort 510 
exerted in reducing reactivation. From the homogeneous frame, an observer would 511 
have likely concluded that the decline had been lower due to some implementational 512 
failure, would have re-estimated the effort to meet the target over the remaining 9 513 
years, now with an intensification to compensate for the lag of the first year. This 514 
process is simulated recursively for 10 years to populate Supplementary Table 1 and 515 
to generate Fig. 3. The insets in Fig. 3b, d, f, depict the relative error committed each 516 
year. 517 
The dynamics of the mean risk of infection in the uninfected and latent compartments 518 
as the described interventions proceeds are shown in Fig. 3a, c, e, to demonstrate the 519 
action of selection. This is the key process leading to the deviation between the 520 
homogeneous and heterogeneous models. 521 
Meeting End TB targets 522 
The model with initial conditions, parameters and distributions estimated for 2002, is 523 
used to reproduce reported country-level trends for TB incidence in Vietnam, Brazil, 524 
and Portugal. Incidence declines between 2002 and 2015, reported by WHO for each 525 
of the three countries, are assigned to changes in pre-specified parameters (here set as 526 𝜙 and 𝜔 for illustrative purposes but alternative combinations have also been used). 527 
The decline is shared among the selected parameters as estimated below.  528 
As incidence declines we monitor the reductions being made on each parameter, 529 
namely, on the probability of progression from primary infection to active disease 530 
[1 − 𝜙(𝑡) 𝜙(2002)⁄ ] and on the reactivation rate [1 − 𝜔(𝑡) 𝜔(2002)⁄ ].  531 
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Parameter estimation 532 
Assuming that the incidence declines reported by WHO between 2002 and 2015 for 533 
Vietnam, Brazil and Portugal, are due to reducing 𝜙 and 𝜔 at constant rates (𝑟a and 534 𝑟a, respectively), resulting in exponentially decaying parameters such that 𝜙(𝑡) =535 𝜙(2002)e]b(_Z#--#)	 and 𝜔(𝑡) = 𝜔(2002)e]^ (_Z#--#), we proceed to estimate 𝑟a and 536 𝑟 . We used a Bayesian Markov Chain Monte Carlo (MCMC) approach to find 537 
posterior sets of these decay rates. We assume gaussian priors and base our likelihood 538 
on the weighted squared error function 539 
𝜒# = 	de𝐵6g − 𝐵6	𝜎6g i#j6k" 																																																																																																				(15) 540 
where 𝐵6g are the data points, 𝐵6 are the model outputs, and 𝜎6g are the corresponding 541 
measurement errors. This is equivalent to using the likelihood (𝐿) such that 𝜒# =542 	−2 log(𝐿), under the assumption of Gaussian noise45,46. In the absence of the 543 
sampling distribution for the data, the error variance is sampled as a conjugate prior   544 
specified by the parameters 𝜎- and 𝑛- of the inverse gamma distribution where 𝜎- is 545 
the initial error variance and 𝑛- is assumed to be 1 (as larger values limit the samples 546 
closer to 𝜎-) 47. We use the MATLAB MCMC package developed by Haario et al. 547 
(2006)48. We initially minimize the error function and use these local minima as 548 
initial values for the parameters in the MCMC run. We infer a MCMC chain of length 549 
105 and adopt a burn in of 2 × 10p  after assessing the Gelman-Rubins-Brooks 550 
potential scale reduction factor (psrf) plots of the posterior distributions (see 551 
Supplementary Figs. 11, 12). 552 
Comparison with metapopulation models 553 
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As implied by Supplementary Fig. 1, geographical units are not conceptualized as 554 
homogeneous patches but rather as harboring heterogeneity down to the individual 555 
level. The transmission dynamics represented in our models is that of a country’s 556 
average patch (with variation in risk among individuals) rather than a metapopulation 557 
consisting of multiple patches (each occupied by a homogeneous population and 558 
variation in risk among patches). To highlight this essential distinction, we have 559 
constructed a metapopulation model consisting of two subpopulations (A and B), each 560 
characterized by a distribution in individual risk (Supplementary Fig. 5).  561 
Subpopulations (or patches) in this toy model are composed of individuals drawn 562 
from a common pool of high and low risk individuals (in proportions 4% and 96%, 563 
respectively), and what characterizes each patch is the fraction of its individuals who 564 
are high-risk (rather than introducing patch-specific effective contact rates, 𝛽q and 𝛽r, 565 
explicitly as commonly practiced). We assume a single 𝛽 for the entire 566 
metapopulation and vary the proportion of individuals in A who are high risk (𝑞#q) 567 
and calculate the corresponding proportion in B (𝑞#r). Basically, we have a family of 568 
metapopulation models, parameterized by the proportion of high-risk individuals in 569 
one of the patches, that we can completely resolve to match the incidence and RIC for 570 
each of our study countries.  571 
We calculate relevant measures, such as variance in individual risk at the level of the 572 
entire metapopulation and 𝑅-. These two metrics are shown as functions of 𝑞#q in 573 
Supplementary Figs. 6 and 7 (for heterogeneous contact rates and heterogeneous 574 
susceptibility, respectively) and one versus the other in Fig. 8. Open and filled circles 575 
are added to Fig. 8 for comparison of the same metrics under the homogeneous and 576 
heterogeneous models used in this study. 577 
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For simplicity we did not include transmission between subpopulations in this 578 
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Fig. 1: Risk inequality coefficient. a, Lorenz curves calculated from notification data 730 
stratified by level 2 administrative divisions (697 districts in Vietnam; 5127 municipalities in 731 
Brazil; 308 municipalities in Portugal). A risk inequality coefficient (RIC) was calculated for 732 
each country from Lorenz curves as in Methods. Country maps with administrative divisions 733 
for Vietnam (b), Brazil (c), and Portugal (d), colored by number of cases notified per 100,000 734 
person-years. 735 
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Fig. 2: Tuberculosis transmission model with distributed contact rates. a, d, g, Risk 739 
(contact rate) distributions inferred by fitting a mathematical model to notification data 740 
stratified in two risk groups (96% and 4% with risk factors 𝛼" and 𝛼#, respectively) as in 741 
Methods (𝛼" = 0.339 and 𝛼# = 16.9 in Vietnam [variance 10.5]; 𝛼" = 0.320 and 𝛼# = 17.3 742 
in Brazil [variance 11.1]; 𝛼" = 0.516 and 𝛼# = 12.6 in Portugal [variance 5.63]). b, e, h, 743 
Risk distributions in the various epidemiological compartments segregated by the 744 
transmission dynamics. Numbers in square brackets represent the mean baseline risk 〈𝛼〉 745 
among individuals populating each epidemiological compartment. c, f, i, Distribution of 746 
incidence rates calculated from stratified model outputs (𝑌" = 0.69 and 𝑌# = 8.5 in Vietnam 747 
[variance 2.3]; 𝑌" = 0.52 and 𝑌# = 12 in Brazil [variance 5.1]; 𝑌" = 0.67 and 𝑌# = 9.0 in 748 
Portugal [variance 2.7]). Model parameters as in Table 1. Clearance of infection upon 749 
successful treatment: 𝜃 = 1. Country-specific parameter values: 𝜔 = 0.0039	yrZ" and 𝛽 =750 3.23	yrZ" in Vietnam; 𝜔 = 0.0013	yrZ" and 𝛽 = 2.94	yrZ" in Brazil; 𝜔 = 0.0013	yrZ" and 751 𝛽 = 4.66	yrZ" in Portugal. Notice that observed incidence variances 〈(𝑌 − 1)#〉 indicate 752 
underlying risk variances 〈(𝛼 − 1)#〉 which are consistently higher11. 753 
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Fig. 3: Moving targets. How (b, d, f) and why (a, c, e) fixed targets appear to be moving 757 
when observed from a homogeneous frame (Methods, and Supplementary Table 1). The 758 
model adopted in this illustration concerns heterogeneity in contact rates as governed by 759 
equations (1)-(5). Mean risks among individuals in uninfected and latent compartments are 760 
calculated as (𝑈"𝛼" + 𝑈#𝛼#) (𝑈" + 𝑈#)⁄  and (𝐿"𝛼" + 𝐿#𝛼#) (𝐿" + 𝐿#)⁄ , respectively. Model 761 
parameters as in Table 1. Clearance of infection upon successful treatment: 𝜃 = 1. Country-762 
specific parameter values: 𝜔 = 0.0039	yrZ", 𝛽 = 3.23	yrZ" (heterogeneous) or 𝛽 =763 10.7	yrZ" (homogeneous) in Vietnam; 𝜔 = 0.0013	yrZ", 𝛽 = 2.94	yrZ" (heterogeneous) or 764 𝛽 = 17.3	yrZ" (homogeneous) in Brazil; 𝜔 = 0.0013	yrZ", 𝛽 = 4.66	yrZ" (heterogeneous) 765 
or 𝛽 = 17.1	yrZ" (homogeneous) in Portugal. 766 
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Fig. 4: Model trajectories with heterogeneity in contact rates and gradual decline in 770 
reactivation (𝝎). TB incidence from 2002 to 2015 (black dots) and model solutions under 771 
heterogeneous contact rates (a, c, e); homogeneous approximation (b, d, f). Initial parameters 772 
values calculated by adjusting the mean effective contact rates (𝛽) to fit 2002 incidence rates: 773 𝛽 = 3.23	yrZ" (a) or 𝛽 = 10.7	yrZ" (b) in Vietnam; 𝛽 = 2.94	yrZ" (c) or 𝛽 = 17.3	yrZ" (d) 774 
in Brazil; 𝛽 = 4.66	yrZ" (e) or 𝛽 = 17.1	yrZ" (f) in Portugal. Incidence declines towards 775 
2015 attributed to reducing reactivation: 𝜔(𝑡) = 𝜔-e]^ (_Z#--#) (where 𝜔- = 0.0039 in 776 
Vietnam and 𝜔- = 0.0013 in Brazil and Portugal), with constant rates 𝑟  adjusted to meet the 777 
incidences observed in 2015 (Supplementary Table 2). From 2020 onwards, the trajectories 778 
split to represent two scenarios: rates of parameter change are maintained (dashed); scale 𝑟  779 
by a factor 𝜅 (represented as “× 𝜅”) to meet WHO incidence targets for 2035 (solid). The 780 
bottom plots in each panel represent the cumulative reductions in reactivation required to 781 
meet the targets calculated as 𝜔w(𝑡) = 1 − 𝜔(𝑡) 𝜔(2002)⁄ . Clearance of infection upon 782 
successful treatment: 𝜃 = 1. Other parameters as in Table 1. Model described by equations 783 
(1)-(5), and 𝑅- given by (6). 784 
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Fig. 5: Model trajectories with heterogeneity in contact rates and gradual declines in 788 
disease progression (𝝓) and reactivation (𝝎). TB incidence from 2002 to 2015 (black dots) 789 
and model solutions under heterogeneous contact rates (a, c, e); homogeneous approximation 790 
(b, d, f). Initial parameters values calculated by adjusting the mean effective contact rates (𝛽) 791 
to fit 2002 incidence rates: 𝛽 = 3.23	yrZ" (a) or 𝛽 = 10.7	yrZ" (b) in Vietnam; 𝛽 =792 2.94	yrZ" (c) or 𝛽 = 17.3	yrZ" (d) in Brazil; 𝛽 = 4.66	yrZ" (e) or 𝛽 = 17.1	yrZ" (f) in 793 
Portugal. Incidence declines towards 2015 attributed to reducing disease progression and 794 
reactivation: 𝜙(𝑡) = 0.05e]b(_Z#--#) and 𝜔(𝑡) = 𝜔-𝑒]^ (_Z#--#) (where 𝜔- = 0.0039 in 795 
Vietnam and 𝜔- = 0.0013 in Brazil and Portugal), with constant rates 𝑟a and 𝑟  estimated 796 
using MCMC (Supplementary Table 3). From 2020 onwards, the trajectories split to represent 797 
four scenarios: rates of parameter change are maintained (dashed black); scale 𝑟a and 𝑟  by a 798 
factor 𝜅 (represented as “× 𝜅”) to meet WHO incidence targets for 2035 (solid black); apply 799 
the same scale up efforts to 𝑟a only (blue) or 𝑟  only (red). The bottom plots in each panel 800 
represent the cumulative reductions in disease progression and reactivation required to meet 801 
the targets calculated as 𝜙z(𝑡) = 1 − 𝜙(𝑡) 𝜙(2002)⁄  and 𝜔w(𝑡) = 1 − 𝜔(𝑡) 𝜔(2002)⁄ , 802 
respectively. Clearance of infection upon successful treatment: 𝜃 = 1. Other parameters as in 803 
Table 1. Model described by equations (1)-(5), and 𝑅- given by (6). 804 
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Fig. 6: Model trajectories with heterogeneity in susceptibility to infection and gradual 808 
declines in disease progression (𝝓) and reactivation (𝝎). TB incidence from 2002 to 2015 809 
(black dots) and model solutions under heterogeneous susceptibility to infection (a, c, e); 810 
cumulative reductions in disease progression and reactivation required to meet End TB 811 
incidence targets (b, d, f), calculated as 𝜙z(𝑡) = 1 − 𝜙(𝑡) 𝜙(2002)⁄  and 𝜔w(𝑡) = 1 −812 𝜔(𝑡) 𝜔(2002)⁄ , respectively. Initial parameter values calculated by adjusting the mean 813 
effective contact rates (𝛽) to fit 2002 incidence rates: 𝛽 = 19.2	yrZ" in Vietnam (a); 𝛽 =814 26.1	yrZ" in Brazil (c); 𝛽 = 21.6	yrZ" in Portugal (e). Incidence declines towards 2015 815 
attributed to reducing disease progression (𝜙) and reactivation (𝜔): 𝜙(𝑡) = 0.05e]b(_Z#--#) 816 
and 𝜔(𝑡) = 𝜔-e]^ (_Z#--#) (where 𝜔- = 0.0039 in Vietnam and 𝜔- = 0.0013 in Brazil and 817 
Portugal), with constant rates 𝑟a and 𝑟  estimated using MCMC (Supplementary Table 8). 818 
From 2020 onwards, the trajectories split to represent four scenarios: rates of parameter 819 
change are maintained (dashed black); scale 𝑟a and 𝑟  by a factor 𝜅 (represented as “× 𝜅”) to 820 
meet WHO incidence target for 2035 (solid black); apply the same scale up efforts to 𝑟a only 821 
(blue) or 𝑟  only (red). Clearance of infection upon successful treatment: 𝜃 = 1. Other 822 
parameters as in Table 1. Model described by equations (1)-(4) and (7), and 𝑅- given by (8). 823 
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Fig. 7: Model trajectories with heterogeneity in disease progression and gradual declines 827 
in progression (𝝓) and reactivation (𝝎). TB incidence from 2002 to 2015 in Portugal (black 828 
dots) and model solutions under heterogeneous progression to disease (c); mean risk 829 
(progression fraction) among susceptible individuals 830 [(𝑈"(𝑡) + 𝐿"(𝑡))𝛼" + (𝑈#(𝑡) + 𝐿#(𝑡))𝛼#] (𝑈"(𝑡) + 𝐿"(𝑡) + 𝑈#(𝑡) + 𝐿#(𝑡))⁄  (b); and 831 
endemic equilibrium parameterized by the mean effective contact rate (𝛽) plotted in terms of 832 𝑅- for the heterogeneous (blue) and homogeneous (black) models (a). Initial parameter values 833 
calculated by adjusting 𝛽 to fit 2002 incidence rates as shown in (a): 𝛽 = 17.1	yrZ". 834 
Incidence declines towards 2015 attributed to reducing disease progression (𝜙) and 835 
reactivation (𝜔): 𝜙(𝑡) = 0.05e]b(_Z#--#) and 𝜔(𝑡) = 𝜔-e]^ (_Z#--#) (where 𝜔- = 0.0039 in 836 
Vietnam and 𝜔- = 0.0013 in Brazil and Portugal), with constant rates 𝑟a and 𝑟  estimated 837 
using MCMC (Supplementary Table 9). From 2020 onwards, the trajectories split to represent 838 
four scenarios: rates of parameter change are maintained (dashed black); scale 𝑟a and 𝑟  by a 839 
factor 𝜅 (represented as “× 𝜅”) to meet WHO incidence target for 2035 (solid black); apply 840 
the same scale up efforts to 𝑟a only (blue) or 𝑟  only (red). Clearance of infection upon 841 
successful treatment: 𝜃 = 1. Other parameters as in Table 1. Model described by equations 842 
(9)-(13), and 𝑅- given by (14). 843 
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Fig. 8: One-parameter family of metapopulation models. (a) Heterogeneous contact rates; 847 
(b) heterogeneous susceptibility to infection. Each point along a solid curve represents one 848 
model that produces country incidences in agreement with RIC values calculated in Fig. 1 849 
(procedures described in Methods). Filled circles marks variances in individual risk and 𝑅- 850 
obtained for each country by the procedure utilized in this study, whereas open circles 851 
indicate 𝑅- estimated by homogeneous approximations.  852 
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Table 1: 854 
Parameters for tuberculosis transmission model.   855 
 856 
Symbol Definition Value 
b Mean effective contact rate estimated 
µ Death and birth rate 1 80⁄ 	yrZ"  
d Rate of progression from primary infection 2	yrZ"  
f Proportion progressing from primary 
infection to active disease 
0.05 
w Rate of reactivation of latent infection 0.0039	yrZ" (Vietnam); 0.0013	yrZ" (Brazil, Portugal) 
t Rate of successful treatment 2	yrZ" 
q Proportion clearing infection upon treatment [0,1] 𝛼6 Individual risk in relation to population 
average 
estimated 𝑝6 Proportion of individuals in low and high risk 
groups, respectively 
𝑝" = 0.96; 𝑝# = 0.04 
 857 
